A rare case report of severe aplastic anaemia caused by long-term use of zidovudine
Zidovudine has bone marrow suppression toxicity, which manifests as anaemia and can occur at any stage of use. Thus, we should not only pay attention to the initial stage of medication but also regularly monitor the patient via routine blood tests in the later stage. If anaemia occurs during the use of zidovudine, physicians should consider the possibility that anaemia is related to the administration of zidovudine and prescribe medication cessation and symptomatic treatment.
Authors
- Congxiang Huang
- Yue Yu (ORCID: https://orcid.org/0000-0002-4758-8492)
- Jing Zhou (ORCID: https://orcid.org/0000-0003-2565-9103)
- Jinchuan Shi (ORCID: https://orcid.org/0000-0003-2582-2660)
- Rangxiao Zhuang (ORCID: https://orcid.org/0000-0003-3239-7658)
- Ling‐Ling Chen (ORCID: https://orcid.org/0000-0002-3005-526X)
- Qi Wang (ORCID: https://orcid.org/0000-0003-0962-4218)
Institutions
- Hangzhou Xixi hospital (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12879-024-09875-z
- Citations
- 2
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.91